Theratechnologies Inc. (TH.TO)
CAD 3.86
(-4.46%)
CAD 3.86
(-4.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -7.53 Million USD | 72.24% |
| 2022 | -27.82 Million USD | -66.36% |
| 2021 | -17.25 Million USD | -77.86% |
| 2020 | -9.17 Million USD | -23045.0% |
| 2019 | -11 Thousand USD | -96.03% |
| 2018 | 788 Thousand USD | 114.73% |
| 2017 | -6.84 Million USD | -250.81% |
| 2016 | 4.53 Million USD | -1.67% |
| 2015 | 4.61 Million USD | 171.24% |
| 2014 | -7.12 Million USD | 35.07% |
| 2013 | -3.68 Million USD | -271.45% |
| 2012 | -3.6 Million USD | 82.79% |
| 2011 | -17.16 Million USD | -276.51% |
| 2010 | 8.84 Million USD | 156.02% |
| 2009 | -13.72 Million USD | 54.33% |
| 2008 | -36.41 Million USD | 5.18% |
| 2007 | -36.4 Million USD | -67.7% |
| 2006 | -21.73 Million USD | -98.32% |
| 2005 | -2.97 Million USD | 39.5% |
| 2004 | -18.16 Million USD | -25.33% |
| 2003 | -14.45 Million USD | -91.66% |
| 2002 | -14.25 Million USD | 77.51% |
| 2001 | -8.17 Million USD | -125.35% |
| 2000 | -6.11 Million USD | -291.35% |
| 1999 | -3.8 Million USD | 8.73% |
| 1998 | -3.71 Million USD | -7.8% |
| 1997 | -4.28 Million USD | 7.0% |
| 1996 | -3.93 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.89 Million USD | 416.14% |
| 2024 Q1 | -1.41 Million USD | -157.74% |
| 2024 Q3 | 6.99 Million USD | 48.15% |
| 2023 FY | - USD | 72.24% |
| 2023 Q4 | 2.44 Million USD | 125.74% |
| 2023 Q2 | -6.8 Million USD | -59.8% |
| 2023 Q1 | -4.26 Million USD | 7.49% |
| 2023 Q3 | 1.08 Million USD | 115.92% |
| 2022 Q4 | -4.6 Million USD | 0.04% |
| 2022 Q3 | -4.6 Million USD | 62.93% |
| 2022 Q2 | -12.43 Million USD | -125.51% |
| 2022 FY | - USD | -66.36% |
| 2022 Q1 | -5.51 Million USD | 5.55% |
| 2021 Q3 | -4.99 Million USD | -59.81% |
| 2021 FY | - USD | -77.86% |
| 2021 Q4 | -5.83 Million USD | -16.93% |
| 2021 Q1 | -2.37 Million USD | -23.97% |
| 2021 Q2 | -3.12 Million USD | -31.55% |
| 2020 Q2 | -2.31 Million USD | -93.48% |
| 2020 Q1 | -1.19 Million USD | 63.43% |
| 2020 FY | - USD | -23045.0% |
| 2020 Q4 | -1.91 Million USD | 48.97% |
| 2020 Q3 | -3.75 Million USD | -62.19% |
| 2019 Q4 | -3.27 Million USD | -312.61% |
| 2019 Q2 | 183 Thousand USD | -88.48% |
| 2019 Q1 | 1.58 Million USD | -21.55% |
| 2019 FY | - USD | -96.03% |
| 2019 Q3 | 1.53 Million USD | 740.44% |
| 2018 Q4 | 2.02 Million USD | 19.47% |
| 2018 FY | - USD | 114.73% |
| 2018 Q1 | -1.52 Million USD | 32.72% |
| 2018 Q2 | -1.22 Million USD | 19.81% |
| 2018 Q3 | 1.69 Million USD | 238.72% |
| 2017 Q1 | 397.24 Thousand USD | -79.53% |
| 2017 FY | - USD | -250.81% |
| 2017 Q4 | -2.26 Million USD | -23.53% |
| 2017 Q3 | -1.83 Million USD | 38.09% |
| 2017 Q2 | -2.96 Million USD | -845.76% |
| 2016 FY | - USD | -1.67% |
| 2016 Q1 | 770.41 Thousand USD | -45.92% |
| 2016 Q2 | 1 Million USD | 30.97% |
| 2016 Q3 | 795.98 Thousand USD | -21.11% |
| 2016 Q4 | 1.94 Million USD | 143.81% |
| 2015 Q2 | 1.52 Million CAD | 2861.98% |
| 2015 Q1 | -55.14 Thousand USD | 95.07% |
| 2015 Q4 | 1.42 Million USD | -21.5% |
| 2015 FY | - USD | 171.24% |
| 2015 Q3 | 1.81 Million USD | 19.14% |
| 2014 FY | - USD | 35.07% |
| 2014 Q4 | -1.11 Million USD | 64.1% |
| 2014 Q3 | -3.11 Million USD | -417.26% |
| 2014 Q2 | 982.41 Thousand USD | 131.42% |
| 2014 Q1 | -3.12 Million USD | 46.58% |
| 2013 FY | - USD | -271.45% |
| 2013 Q2 | -1.27 Million USD | -12.96% |
| 2013 Q4 | -5.85 Million USD | -226.3% |
| 2013 Q1 | -1.12 Million USD | -308.38% |
| 2013 Q3 | -1.79 Million USD | -41.24% |
| 2012 Q4 | 539.55 Thousand USD | 186.56% |
| 2012 FY | - USD | 82.79% |
| 2012 Q3 | -623.33 Thousand USD | 46.56% |
| 2012 Q2 | -1.16 Million USD | 8.32% |
| 2012 Q1 | -1.27 Million USD | -81.42% |
| 2011 Q3 | -3.54 Million USD | 39.84% |
| 2011 Q2 | -5.89 Million USD | -10.98% |
| 2011 Q1 | -5.31 Million USD | -123.88% |
| 2011 FY | - USD | -276.51% |
| 2011 Q4 | -701.33 Thousand USD | 80.23% |
| 2010 Q4 | 22.25 Million USD | 774.83% |
| 2010 Q3 | -3.29 Million USD | 30.53% |
| 2010 Q2 | -4.74 Million USD | -6.2% |
| 2010 Q1 | -4.46 Million USD | 13.32% |
| 2010 FY | - USD | 156.02% |
| 2009 Q3 | 4.96 Million USD | 191.9% |
| 2009 Q2 | -5.39 Million USD | 38.79% |
| 2009 FY | - USD | 54.33% |
| 2009 Q4 | -5.15 Million USD | -203.96% |
| 2009 Q1 | -8.81 Million USD | -161.41% |
| 2008 Q4 | -3.37 Million CAD | 67.34% |
| 2008 Q2 | -11.21 Million CAD | -3.62% |
| 2008 Q1 | -10.82 Million CAD | -2.17% |
| 2008 FY | - USD | 5.18% |
| 2008 Q3 | -10.32 Million CAD | 7.88% |
| 2007 Q4 | -10.59 Million CAD | -9.09% |
| 2007 Q2 | -7.22 Million CAD | 8.05% |
| 2007 FY | - USD | -67.7% |
| 2007 Q1 | -7.85 Million CAD | -47.06% |
| 2007 Q3 | -9.7 Million CAD | -34.38% |
| 2006 Q3 | -6.31 Million CAD | -16.62% |
| 2006 FY | - USD | -98.32% |
| 2006 Q1 | -4.71 Million CAD | -5.83% |
| 2006 Q2 | -5.41 Million CAD | -14.9% |
| 2006 Q4 | -5.34 Million CAD | 15.35% |
| 2005 FY | - USD | 39.5% |
| 2005 Q4 | -4.45 Million CAD | -11.56% |
| 2005 Q3 | -3.98 Million USD | -244.66% |
| 2005 Q2 | 2.75 Million CAD | 185.12% |
| 2005 Q1 | -3.24 Million CAD | 42.21% |
| 2004 FY | - USD | -25.33% |
| 2004 Q4 | -5.6 Million CAD | -42.49% |
| 2004 Q3 | -3.93 Million USD | 22.67% |
| 2004 Q1 | -8.37 Million CAD | -159.2% |
| 2004 Q2 | -5.08 Million CAD | 39.24% |
| 2003 FY | - USD | -91.66% |
| 2003 Q4 | 3.91 Million CAD | 412.69% |
| 2003 Q3 | -4.41 Million CAD | -58.35% |
| 2003 Q2 | -4.08 Million CAD | 19.47% |
| 2003 Q1 | -3.18 Million CAD | 35.8% |
| 2002 Q1 | -4.64 Million CAD | -948.55% |
| 2002 Q3 | -3.68 Million CAD | 46.07% |
| 2002 Q4 | -4.91 Million CAD | -35.25% |
| 2002 FY | - USD | 77.51% |
| 2002 Q2 | -3.86 Million CAD | -0.06% |
| 2001 FY | - USD | -125.35% |
| 2001 Q4 | -562.49 Thousand CAD | 103.47% |
| 2001 Q3 | -3.06 Million CAD | -323.76% |
| 2001 Q2 | -2.27 Million CAD | -145.29% |
| 2001 Q1 | -2.2 Million CAD | 60.63% |
| 2000 FY | - USD | -291.35% |
| 2000 Q1 | -1.24 Million CAD | -9.71% |
| 2000 Q2 | -1.6 Million USD | -17.23% |
| 2000 Q3 | -1.29 Million USD | -270.06% |
| 2000 Q4 | -1.91 Million CAD | -10.72% |
| 1999 Q4 | -1.19 Million USD | -27.41% |
| 1999 Q2 | -1.01 Million USD | -31.54% |
| 1999 Q1 | -928.07 Thousand USD | -35.18% |
| 1999 FY | - USD | 8.73% |
| 1999 Q3 | -936.73 Thousand USD | 23.27% |
| 1998 FY | - USD | -7.8% |
| 1998 Q4 | -737 Thousand USD | 42.89% |
| 1998 Q1 | -1.05 Million USD | -45.55% |
| 1998 Q3 | -1.01 Million USD | 16.61% |
| 1998 Q2 | -1.23 Million USD | -20.7% |
| 1997 Q1 | -1.09 Million USD | 0.0% |
| 1997 FY | - USD | 7.0% |
| 1997 Q2 | -1.52 Million USD | -39.02% |
| 1997 Q3 | -1.07 Million USD | 19.68% |
| 1997 Q4 | -759 Thousand USD | 32.95% |
| 1996 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 136.822% |
| Avicanna Inc. | -7.35 Million CAD | -2.495% |
| Avant Brands Inc. | 4.83 Million CAD | 255.893% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 72.959% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 16853.333% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 118.434% |
| MediPharm Labs Corp. | -10.47 Million CAD | 28.049% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 96.369% |
| Canopy Growth Corporation | -312.82 Million CAD | 97.59% |
| Willow Biosciences Inc. | -11.06 Million CAD | 31.842% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | 30.356% |